Antigens of the type-three secretion system of Aeromonas salmonicida subsp. salmonicida prevent protective immunity in rainbow trout

Vaccine

Volumn 31, Issue 45, 2013, Pages 5256-5261

  Bergh, Philippe Vanden ^a   Burr, Sarah E ^b   Benedicenti, Ottavia ^c   von Siebenthal, Beat ^a   Frey, Joachim ^a   Wahli, Thomas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

Author keywords

AcrV; Aeromonas salmonicida; Furunculosis; Inhibition of immune protection; T3SS; Type three secretion system; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIN; RECOMBINANT ANTIGEN; RECOMBINANT ANTIGEN ACRV; RECOMBINANT ANTIGEN VAPA; UNCLASSIFIED DRUG;

AEROMONAS SALMONICIDA; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FURUNCULOSIS; GENE DELETION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAINBOW TROUT; TYPE III SECRETION SYSTEM; VACCINATION;

ACRV; AEROMONAS SALMONICIDA; FURUNCULOSIS; INHIBITION OF IMMUNE PROTECTION; T3SS; TYPE-THREE SECRETION SYSTEM; VACCINE;

AEROMONAS SALMONICIDA; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL SECRETION SYSTEMS; BACTERIAL VACCINES; FISH DISEASES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; IMMUNOSUPPRESSIVE AGENTS; ONCORHYNCHUS MYKISS; SURVIVAL ANALYSIS; VIRULENCE FACTORS;

EID: 84885961069     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.057     Document Type: Article

References (50)

1. Lehmann K.B., Neumann R. Atlas und Grundriss der Bakteriologie und Lehrbuch der speziellen bakteriologischen Diagnostik 1896, Lehmann, München. 1st ed.
2. Austin B., Austin D.A. Aeromonadaceae Representative (Aeromonas salmonicida). Bacterial fish pathogens: disease of farmed and wild fish 2012, 147-228. Springer. Fifth ed.
3. Duff D.C.B. The oral immunization of trout against Bacterium salmonicida. J Immunol 1942, 44:87-94.
4. Paterson W.D., Lall S.P., Airdrie D., Greer P., Greenham G., Poy M. Prevetion of disease in salmonids by vaccination and dietary modification. Fish Pathol 1985, 20:427-434.
5. Cipriano R.C. Immunization of brook trout (Salvelinus fontinalis) against Aeromonas salmonicida - immunogenicity of virulent and avirulent isolates and protective ability of different antigens. Can J Fish Aquat Sci 1982, 39(1):218-221.
6. Michel C., Faivre B. Occurrence and significance of agglutinating antibodies in experimental furunculosis of rainbow trout, Salmo gairdneri Richardson. J Fish Dis 1982, 5(5):429-432.
7. Olivier G., Evelyn T.P.T., Lallier R. Immunogenicity of vaccines from a virulent and an avirulent strain of Aeromonas salmonicida. J Fish Dis 1985, 8(1):43-55.
8. Olivier G., Evelyn T.P., Lallier R. Immunity to Aeromonas salmonicida in coho salmon (Oncorhynchus kisutch) induced by modified Freund's complete adjuvant: its non-specific nature and the probable role of macrophages in the phenomenon. Dev Comp Immunol 1985, 9(3):419-432.
9. Marquis H., Lallier R. Efficacy studies of passive immunization against Aeromonas salmonicida infection in brook trout, Salvelinus fontinalis (Mitchill). J Fish Dis 1989, 12(3):233-240.
10. Ellis A.E., Burrows A.S., Hastings T.S., Stapleton K.J. Identification of Aeromonas salmonicida extracellular protease as a protective antigen against Furunculosis by passive-immunization. Aquaculture 1988, 70(May (3)):207-218.
11. Romer V.K., Dalsgaard I., Holten-Andersen L., Raida M.K. Potential role of specific antibodies as important vaccine induced protective mechanism against Aeromonas salmonicida in rainbow trout. PLoS ONE 2012, 7(10):e46733.
12. Romstad A.B., Reitan L.J., Midtlyng P., Gravningen K., Evensen O. Antibody responses correlate with antigen dose and in vivo protection for oil-adjuvanted, experimental furunculosis (Aeromonas salmonicida subsp salmonicida) vaccines in Atlantic salmon (Salmo salar L.) and can be used for batch potency testing of vaccines. Vaccine 2013, 31(5):791-796.
13. Lund V., Arne A.J., Coucheron D., Modalsli K., Syvertsen C. The Aeromonas salmonicida A-layer protein is an important protective antigen in oil-adjuvanted vaccines. Fish Shellfish Immunol 2003, 15(4):367-372.
14. Burr S.E., Stuber K., Wahli T., Frey J. Evidence for a type III secretion system in Aeromonas salmonicida subsp salmonicida. J Bact 2002, 184(21):5966-5970.
15. Stuber K., Burr S.E., Braun M., Wahli T., Frey J. Type III secretion genes in Aeromonas salmonicida subsp salmonicida are located on a large thermolabile virulence plasmid. J Clin Microbiol 2003, 41(8):3854-3856.
16. Burr S.E., Wahli T., Segner H., Pugovkin D., Frey J. Association of Type III secretion genes with virulence of Aeromonas salmonicida subsp. salmonicida. Dis Aquat Org 2003, 57(1/2):167-171.
17. Dacanay A., Knickle L., Solanky K.S., Boyd J.M., Walter J.A., Brown L.L., et al. Contribution of the type III secretion system (TTSS) to virulence of Aeromonas salmonicida subsp. salmonicida. Microbiology-SGM 2006, 152:1847-1856.
18. Burr S.E., Pugovkin D., Wahli T., Segner H., Frey J. Attenuated virulence of an Aeromonas salmonicida subsp salmonicida type III secretion mutant in a rainbow trout model. Microbiology-SGM 2005, 151:2111-2118.
19. Fehr D., Casanova C., Liverman A., Blazkova H., Orth K., Dobbelaere D., et al. AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway. Microbiology 2006, 152(9):2809-2818.
20. Burr S.E., Stuber K., Frey J. The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a type III secretion pathway. J Bact 2003, 185(November (22)):6583-6591.
21. Braun M., Stuber K., Schlatter Y., Wahli T., Kuhnert P., Frey J. Characterization of an ADP-ribosyltransferase toxin (AexT) from Aeromonas salmonicida subsp. salmonicida. J Bact 2002, 184(7):1851-1858.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
23. Gunasekera K., Wuthrich D., Braga-Lagache S., Heller M., Ochsenreiter T. Proteome remodelling during development from blood to insect-form Trypanosoma brucei quantified by SILAC and mass spectrometry. BMC Genom 2012, 13:556.
24. Al Kaabi A., Traupe T., Stutz M., Buchs N., Heller M. Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy. PLoS ONE 2012, 7(October (10)).
25. Stalder D., Haeberli A., Heller M. Evaluation of reproducibility of protein identification results after multidimensional human serum protein separation. Proteomics 2008, 8(February (3)):414-424.
26. Gluck F., Hoogland C., Antinori P., Robin X., Nikitin F., Zufferey A., et al. EasyProt - an easy-to-use graphical platform for proteomics data analysis. J Proteomics 2013, 79(February (21)):146-160.
27. Al Kaabi A., Traupe T., Stutz M., Buchs N., Heller M. Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy. PLoS ONE 2012, 7(October (10)):e46822.
28. Guex N., Peitsch M.C. SWISS-MODEL the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18(15):2714-2723.
29. Blocker A.J., Deane J.E., Veenendaal A.K.J., Roversi P., Hodgkinson J.L., Johnson S., et al. What's the point of the type III secretion system needle?. Proc Natl Acad Sci USA 2008, 105(18):6507-6513.
30. Brubaker R.R. Interleukin-10 and inhibition of innate immunity to yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003, 71(7):3673-3681.
31. Sodhi A., Sharma R.K., Batra H.V., Tuteja U. Mechanism of rLcrV and rYopB mediated immunosuppression in murine peritoneal macrophages. Mol Immunol 2004, 41(8):767-774.
32. Yao T., Mecsas J., Healy J.I., Falkow S., Chien Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 1999, 190(9):1343-1350.
33. Aepfelbacher M. Modulation of Rho GTPases by type III secretion system translocated effectors of Yersinia. Rev Physiol Biochem Pharmacol 2004, 152:65-77.
34. Paquette N., Conlon J., Sweet C., Rus F., Wilson L., Pereira A., et al. Serine/threonine acetylation of TGFbeta-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc Natl Acad Sci USA 2012, 109(31):12710-12715.
35. Park H., Teja K., O'Shea J.J., Siegel R.M. The Yersinia effector protein YpkA induces apoptosis independently of actin depolymerization. J Immunol 2007, 178(10):6426-6434.
36. Nagamatsu K., Kuwae A., Konaka T., Nagai S., Yoshida S., Eguchi M., et al. Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med 2009, 206(13):3073-3088.
37. Bi Y.J., Du Z.M., Han Y.P., Yang H.Y., Bi Y.J., Wang G.Q., et al. Yersinia pestis and host macrophages: immunodeficiency of mouse macrophages induced by YscW. Immunology 2009, 128(1):e406-e417.
38. Nakajima R., Brubaker R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993, 61(1):23-31.
39. Nakajima R., Motin V.L., Brubaker R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 1995, 63(August (8)):3021-3029.
40. Sing A., Roggenkamp A., Geiger A.M., Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 2002, 168(3):1315-1321.
41. Overheim K.A., DePaolo R.W., Debord K.L., Morrin E.M., Anderson D.M., Green N.M., et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 2005, 73(8):5152-5159.
42. DePaolo R.W., Tang F.M., Kim I., Han M., Levin N., Ciletti N., et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008, 4(4):350-361.
43. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002, 196(8):1017-1024.
44. Fadl A.A., Galindo C.L., Sha J., Erova T.E., Houston C.W., Olano J.P., et al. Deletion of the genes encoding the type III secretion system and cytotoxic enterotoxin alters host responses to Aeromonas hydrophila infection. Microb Pathog 2006, 40(5):198-210.
45. Villarino Romero R., Bibova I., Cerny O., Vecerek B., Wald T., Benada O., et al. Bordetella pertussis T3SS tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infections of men or mice. Infect Immun 2013, 81(8):2761-2767.
46. Druar C., Yu F., Barnes J.L., Okinaka R.T., Chantratita N., Beg S., et al. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. FEMS Immunol Med Microbiol 2008, 52(1):78-87.
47. Stevens M.P., Haque A., Atkins T., Hill J., Wood M.W., Easton A., et al. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology-SGM 2004, 150:2669-2676.
48. Hill J., Leary S.E., Griffin K.F., Williamson E.D., Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 1997, 65(11):4476-4482.
49. Cornelius C.A., Quenee L.E., Overheim K.A., Koster F., Brasel T.L., Elli D., et al. Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Infect Immun 2008, 76(12):5588-5597.
50. Quenee L.E., Berube B.J., Segal J., Elli D., Ciletti N.A., Anderson D., et al. Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 2010, 28(7):1870-1876.